Services
We provide two services: OncoAct and Hartwig Sequencing Services.
OncoAct
Cancer is caused by DNA mutations. To find these mutations, we developed OncoAct. OncoAct is a complete DNA test that can provide physicians with additional information about clinically relevant characteristics of a tumor (biomarkers) that may also be predictive of the response to treatment.
Changes in the genetic profile (mutations) sometimes provide clues to a potential treatment that can directly target these mutations. This is known as targeted therapy.
In addition, the OncoAct report contains possible leads for trials or experimental drugs.
Sequencing Services
We sequence and analyze DNA for research purposes.
The complete DNA test is an additional tool to help us discover the origin of the cancer in patients with CUP, often enabling us to identify this primary tumor. In addition, the test often reveals new options for targeted treatment.